{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:29:27Z","timestamp":1785522567808,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL007093"],"award-info":[{"award-number":["T32 HL007093"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtct.2023.08.021","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T05:47:02Z","timestamp":1692942422000},"page":"696.e1-696.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based Transplantations"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-4578","authenticated-orcid":false,"given":"Andrew J.","family":"Portuguese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-1446","authenticated-orcid":false,"given":"Damian J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-8688","authenticated-orcid":false,"given":"Marco","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-7360","authenticated-orcid":false,"given":"Albert C.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.08.021_bib0001","first-page":"265","article-title":"Early infectious complications in autologous bone marrow transplantation: a review of 219 patients","volume":"18","author":"Mossad","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2006-945530","article-title":"Major complications following hematopoietic stem cell transplantation","volume":"27","author":"Afessa","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2023.08.021_bib0003","first-page":"118","article-title":"Complications and risks in hematopoietic stem cell transplant patients","volume":"14","author":"Smith","year":"2001","journal-title":"Clin Lab Sci"},{"key":"10.1016\/j.jtct.2023.08.021_bib0004","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0005","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0006","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/bmt.2009.75","article-title":"Optimal use of G-CSF administration after hematopoietic SCT","volume":"43","author":"Trivedi","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0007","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.1995.13.6.1323","article-title":"Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial","volume":"13","author":"Klumpp","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0008","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1200\/JCO.1997.15.2.451","article-title":"Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit","volume":"15","author":"McQuaker","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0009","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1600-0609.2006.00741.x","article-title":"Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma: results of a prospective multicentre controlled trial","volume":"77","author":"Faber","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1704724","article-title":"Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial","volume":"34","author":"Schmitz","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0011","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1703539","article-title":"The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period","volume":"29","author":"Hornedo","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0012","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/bjc.1998.216","article-title":"Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost","volume":"77","author":"Lee","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2023.08.021_bib0013","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.bmt.1701972","article-title":"A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults","volume":"24","author":"Ojeda","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0014","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.bmt.1701795","article-title":"Optimal timing of G-CSF administration after CD34+ immunoselected peripheral blood progenitor cell transplantation","volume":"23","author":"Piccirillo","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0015","first-page":"271","article-title":"Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation","volume":"13","author":"Shimazaki","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705097","article-title":"Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial","volume":"36","author":"Valteau-Couanet","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0017","first-page":"103","article-title":"Stem cell transplantation and hematopoietic growth factors","volume":"1","author":"Richard","year":"2002","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.jtct.2023.08.021_bib0018","unstructured":"National Comprehensive Cancer Network (NCCN). Hematopoietic growth factors (version 4.2021, May 20, 2021). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf. Accessed June 14, 2021."},{"key":"10.1016\/j.jtct.2023.08.021_bib0019","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","article-title":"Factors that influence collection and engraftment of autologous peripheral-blood stem cells","volume":"13","author":"Bensinger","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0020","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2005.01.067","article-title":"Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease","volume":"46","author":"Hill","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1)","key":"10.1016\/j.jtct.2023.08.021_bib0021","first-page":"S166","article-title":"G-CSF-induced mobilization of CD34(+) progenitor cells and proarrhythmic effects in patients with severe coronary artery disease","volume":"30","author":"Wolfram","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.08.021_bib0022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","article-title":"FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas","volume":"44","author":"Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jtct.2023.08.021_bib0023","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.08.021_bib0024","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.bmt.1702816","article-title":"Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation","volume":"27","author":"Ozcan","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0025","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1365-2141.2002.03762.x","article-title":"Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation","volume":"118","author":"Demirer","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0026","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.1994.425","article-title":"Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue","volume":"70","author":"Dunlop","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2023.08.021_bib0027","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.bmt.1703079","article-title":"Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells","volume":"27","author":"Osma","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0028","first-page":"779","article-title":"Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery","volume":"14","author":"Vey","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0029","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1701104","article-title":"G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs","volume":"21","author":"Tarella","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0030","first-page":"51","article-title":"Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas","volume":"14","author":"Brice","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.021_bib0031","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.1995.13.4.935","article-title":"Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma","volume":"13","author":"Cortelazzo","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.021_bib0032","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clml.2015.05.008","article-title":"BEAM conditioning regimen has higher toxicity compared with high-dose melphalan for salvage autologous hematopoietic stem cell transplantation in multiple myeloma","volume":"15","author":"Veeraputhiran","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2023.08.021_bib0033","unstructured":"Pfizer. Information for Colorado prescribers of prescription drugs. Nivestym (filgrastim-aafi). February 10, 2022."},{"key":"10.1016\/j.jtct.2023.08.021_bib0034","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cncr.23281","article-title":"In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample","volume":"112","author":"Jones","year":"2008","journal-title":"Cancer"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:04Z","timestamp":1763003464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723015038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666636723015038"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.021","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based Transplantations","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}